Yes, Canadian drug companies are falling way behind in R&D investment. It is time to take away that intellectual property protections they want, although with NAFTA and now CETA that will be hard. I had a neighbor that was heavily involved in the industry several years ago and she said a lot of the focus was on clinical testing and not basic research, but even that was drying up quickly. The real leaders are Switzerland, Germany, Italy, the U.K, France and Sweden.